Cargando…

Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study

PURPOSE: The aim of this study is to investigate the prevention and treatment patterns of deep vein thrombosis (DVT) in critically ill patients and to explore the risk factors for DVT in people from Zhejiang Province, China. MATERIALS AND METHODS: This study prospectively enrolled patients admitted...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Zhou, Jia, Huang, Liquan, Zhen, Junhai, Yao, Lina, Xu, Lingen, Zhang, Weimin, Zhang, Gensheng, Chen, Qijiang, Cheng, Bihuan, Gong, Shijin, Cai, Guolong, Jiang, Ronglin, Yan, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805816/
https://www.ncbi.nlm.nih.gov/pubmed/34797177
http://dx.doi.org/10.1080/07853890.2021.2005822
_version_ 1784643300879237120
author Li, Li
Zhou, Jia
Huang, Liquan
Zhen, Junhai
Yao, Lina
Xu, Lingen
Zhang, Weimin
Zhang, Gensheng
Chen, Qijiang
Cheng, Bihuan
Gong, Shijin
Cai, Guolong
Jiang, Ronglin
Yan, Jing
author_facet Li, Li
Zhou, Jia
Huang, Liquan
Zhen, Junhai
Yao, Lina
Xu, Lingen
Zhang, Weimin
Zhang, Gensheng
Chen, Qijiang
Cheng, Bihuan
Gong, Shijin
Cai, Guolong
Jiang, Ronglin
Yan, Jing
author_sort Li, Li
collection PubMed
description PURPOSE: The aim of this study is to investigate the prevention and treatment patterns of deep vein thrombosis (DVT) in critically ill patients and to explore the risk factors for DVT in people from Zhejiang Province, China. MATERIALS AND METHODS: This study prospectively enrolled patients admitted in intensive care units (ICUs) of 54 hospitals from 09/16/2019 to 01/16/2020. The risk of developing DVT and subsequent prophylaxis was evaluated. The primary outcome was DVT occurrence during ICU hospitalisation. Univariate and multivariate logistic regression were performed to determine the risk factors for DVT. RESULTS: A total of 940 patients were included in the study. Among 847 patients who received prophylaxis, 635 (75.0%) patients received physical prophylaxis and 199 (23.5%) patients received drug prophylaxis. Fifty-eight (6.2%) patients were diagnosed with DVT after admission to the ICU, and 36 patients were treated with anticoagulants (all patients received low molecular weight heparin [LMWH]). D-dimer levels (OR = 1.256, 95% CI: 1.132–1.990), basic prophylaxis (OR = 0.092, 95% CI: 0.016–0.536), and physical prophylaxis (OR = 0.159, 95% CI: 0.038–0.674) were independently associated with DVT in ICU patients. The short-term survival was similar between DVT and non-DVT patients. CONCLUSIONS: DVT prophylaxis is widely performed in ICU patients. Prophylaxis is an independent protective factor for DVT occurrence. The most common treatment of DVT patients is LMWH, although it might increase the rate of bleeding. KEY MESSAGES: This is the only multicenter and prospective study of DVT in ICUs in China. d-dimer levels were independently associated with DVT in ICU patients. Prophylaxis was an independent protective factor for DVT occurrence in ICU.
format Online
Article
Text
id pubmed-8805816
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88058162022-02-02 Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study Li, Li Zhou, Jia Huang, Liquan Zhen, Junhai Yao, Lina Xu, Lingen Zhang, Weimin Zhang, Gensheng Chen, Qijiang Cheng, Bihuan Gong, Shijin Cai, Guolong Jiang, Ronglin Yan, Jing Ann Med Cardiology & Cardiovascular Disorders PURPOSE: The aim of this study is to investigate the prevention and treatment patterns of deep vein thrombosis (DVT) in critically ill patients and to explore the risk factors for DVT in people from Zhejiang Province, China. MATERIALS AND METHODS: This study prospectively enrolled patients admitted in intensive care units (ICUs) of 54 hospitals from 09/16/2019 to 01/16/2020. The risk of developing DVT and subsequent prophylaxis was evaluated. The primary outcome was DVT occurrence during ICU hospitalisation. Univariate and multivariate logistic regression were performed to determine the risk factors for DVT. RESULTS: A total of 940 patients were included in the study. Among 847 patients who received prophylaxis, 635 (75.0%) patients received physical prophylaxis and 199 (23.5%) patients received drug prophylaxis. Fifty-eight (6.2%) patients were diagnosed with DVT after admission to the ICU, and 36 patients were treated with anticoagulants (all patients received low molecular weight heparin [LMWH]). D-dimer levels (OR = 1.256, 95% CI: 1.132–1.990), basic prophylaxis (OR = 0.092, 95% CI: 0.016–0.536), and physical prophylaxis (OR = 0.159, 95% CI: 0.038–0.674) were independently associated with DVT in ICU patients. The short-term survival was similar between DVT and non-DVT patients. CONCLUSIONS: DVT prophylaxis is widely performed in ICU patients. Prophylaxis is an independent protective factor for DVT occurrence. The most common treatment of DVT patients is LMWH, although it might increase the rate of bleeding. KEY MESSAGES: This is the only multicenter and prospective study of DVT in ICUs in China. d-dimer levels were independently associated with DVT in ICU patients. Prophylaxis was an independent protective factor for DVT occurrence in ICU. Taylor & Francis 2021-11-19 /pmc/articles/PMC8805816/ /pubmed/34797177 http://dx.doi.org/10.1080/07853890.2021.2005822 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiology & Cardiovascular Disorders
Li, Li
Zhou, Jia
Huang, Liquan
Zhen, Junhai
Yao, Lina
Xu, Lingen
Zhang, Weimin
Zhang, Gensheng
Chen, Qijiang
Cheng, Bihuan
Gong, Shijin
Cai, Guolong
Jiang, Ronglin
Yan, Jing
Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study
title Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study
title_full Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study
title_fullStr Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study
title_full_unstemmed Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study
title_short Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study
title_sort prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in zhejiang province, china: a multicenter, prospective, observational study
topic Cardiology & Cardiovascular Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805816/
https://www.ncbi.nlm.nih.gov/pubmed/34797177
http://dx.doi.org/10.1080/07853890.2021.2005822
work_keys_str_mv AT lili preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT zhoujia preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT huangliquan preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT zhenjunhai preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT yaolina preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT xulingen preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT zhangweimin preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT zhanggensheng preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT chenqijiang preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT chengbihuan preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT gongshijin preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT caiguolong preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT jiangronglin preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT yanjing preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy
AT preventiontreatmentandriskfactorsofdeepveinthrombosisincriticallyillpatientsinzhejiangprovincechinaamulticenterprospectiveobservationalstudy